Superbug Alert: Drug-Resistant Yeast Spreads

A highly drug-resistant fungus, Candida auris, identified as a 'superbug,' is showing an increasing presence across the United States. As of August 1, 2026, provisional data from the Centers for Disease Control and Prevention reveals significant case counts in several states, with Texas reporting 706 cases and Michigan documenting 503. Tennessee has also seen a rise, recording 293 cases in 2026.

This resilient yeast, first discovered in Japan in 2009, is known for its ability to resist antifungal treatments and disinfectants, allowing it to persist on surfaces for extended periods. Its transmission typically occurs in healthcare environments through direct contact with infected individuals or contaminated equipment such as bedrails and blood pressure cuffs. Medical devices like breathing tubes and catheters also serve as common vectors for the fungus.

Symptoms of Candida auris infection can be subtle and often overlap with existing conditions in already ill patients, leading to diagnostic challenges. Common signs include fever, chills, extreme tiredness, low blood pressure, and pain. Without prompt and effective treatment, complications can escalate to sepsis, shock, and organ failure, particularly impacting individuals in long-term care facilities.

While cases are increasing, health officials emphasize that the general public is at low risk. The primary concern remains for severely ill patients within long-term healthcare settings. Health departments are implementing precautionary measures to mitigate spread, including rapid detection and response protocols when outbreaks are identified.